Pharmaceutical advertisement claims in Australian medical publications: Is evidence accessible, compelling and communicated comprehensively?

Medical Journal of Australia

Volumn 177, Issue 6, 2002, Pages 291-293

  Loke, Tim W ^b,c   Koh, Fong Chee ^b,d   Ward, Jeanette E ^a,e  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b University of Sydney   (Australia)

^c NATIONAL HEALTHCARE GROUP   (Singapore)

^d ALEXANDRA HOSPITAL   (Singapore)

^e CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; EVIDENCE BASED MEDICINE; GOOD MANUFACTURING PRACTICE; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL AUDIT; MEDICAL LITERATURE; METHODOLOGY; OUTCOMES RESEARCH; PUBLICATION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SAMPLE;

EID: 0037120605     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04785.x     Document Type: Article

References (20)

1. Levy R. The role and value of pharmaceutical marketing. Arch Fam Med 1994; 3: 327-332.
2. Roughead EE. The Australian Pharmaceutical Manufacturers Association Code of Conduct: Guiding the promotion of prescription medicines. Aust Prescr 1999; 22: 78-80.
3. Harvey K. Pharmaceutical promotion. Med J Aust 1990; 152: 57-59.
4. Moulds R, Bochner F, Wing L. Drug advertising [letter]. Med J Aust 1986; 145: 178-179.
5. Moulds R, Wing L, Shenfield G, Day R. Drug advertising [letter]. Med J Aust 1987; 147: 52.
6. Moulds R, Wing L. Drug advertising [letter]. Med J Aust 1989; 150: 410-411.
7. Carandang E, Molds RF. Pharmaceutical advertisements in Australian medical publications - Have they improved? Med J Aust 1994; 161: 671-672.
8. Lexchin J. How patient outcomes are reported in advertisements: Review of Canadian medical journals. Can Fam Physician 1999; 45: 1213-1216.
9. Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 2001; 14: 197-200.
10. Young J, Glasziou P, Ward JE. General practitioners' self ratings of skills in evidence based medicine: Validation study. BMJ 2002; 324; 950-951.
11. Tutorials in evidence-based medicine. . Accessed 13 May 2002.
12. Bobbio M, Dimichelis B, Giustello G. Completeness of reporting trial results: Effect on physicians' willingness to prescribe. Lancet 1994; 343: 1209-1211.
13. Naylor D, Chen E, Strauss B. Measured enthusiasm: Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992; 117: 916-921.
14. Forrow L, Taylor W, Armold R. Absolutely relative: How research results are summarized can affect treatment decisions. Am J Med 1992; 92: 121-124.
15. Muir Gray JA. Evidence-Based Health Care: How to Make Health Policy and Management Decisions. 2nd ed. Edinburgh: Churchill Livingstone, 2001.
16. Levels of evidence and grades of recommendations. Oxford Centre for Evidence Based Medicine. . Accessed 1 August 2002.
17. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1992.
18. Cook RJ, Sackett DL. The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995; 310: 452-454.
19. Sackett DI, Haynes RB. Summarizing the effects of therapy: A new table and some more terms [letter]. ACP J Club 1997; 127: A15-A16.
20. McLaren H. Evidence-based medicine in editorials [rapid response]. . Accessed 3 May 2002.